The Role of Urinary ATP in the Diagnosis, Treatment, and Follow-up of Children with Overactive Bladder
NCT06785558 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2025-01-21
Summary
In this study, the investigators aim to evaluate the role of urinary ATP as a biomarker for the diagnosis, treatment, and follow-up of OAB in children for the first time in a clinical investigation, as previous research has been limited to adults.
Conditions
- Overactive Bladder (OAB)
Interventions
- DRUG
-
Anticholinergic therapy
Overactive bladder group use anticholinergic drug and 1 month later their urinary atp levels calculated again
Sponsors & Collaborators
-
Marmara University
lead OTHER
Principal Investigators
-
CAGRI AKIN SEKERCİ · MARMARA UNİVERSİTY SCHOOL OF MEDİCİNE DEPARTMENT OF UROLOGY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 4 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2024-09-01
- Completion
- 2024-11-15
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study
NCT06563193 ·Status: ENROLLING_BY_INVITATION
-
Ability to Awaken in Nonmonosymptomatic Enuresis
NCT02845648 ·Status: COMPLETED
-
Pharmacokinetics, Safety and Tolerability of Tamsulosin Hydrochloride in Children With Voiding Disorders
NCT02266524 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB)
NCT04641975 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of YM178 in Subjects With Symptoms of Overactive Bladder
NCT01043666 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of the Efficacy of Treatment of Idiopathic Overactive Bladder (OAB) in Children: Oxybutynine vs. Transcutaneous Neurostimulation
NCT07030803 ·Status: RECRUITING ·Phase: NA
-
A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis
NCT00245479 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder
NCT01192568 ·Status: COMPLETED ·Phase: PHASE4
-
Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity
NCT02751931 ·Status: COMPLETED ·Phase: PHASE3
-
Behavioural Therapy With Checklist for Overactive Bladder
NCT03662893 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition
NCT00224016 ·Status: COMPLETED ·Phase: PHASE4
-
A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity
NCT00712322 ·Status: TERMINATED ·Phase: PHASE2
-
Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder
NCT01539707 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population
NCT02584231 ·Status: COMPLETED ·Phase: PHASE4
-
Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years
NCT00857896 ·Status: COMPLETED ·Phase: PHASE2
-
PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder
NCT00340704 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder
NCT00795925 ·Status: COMPLETED ·Phase: PHASE2
-
ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients
NCT04626960 ·Status: COMPLETED
-
Efficacy of 200 IU OnabotulinumtoxinA in Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment
NCT06408051 ·Status: COMPLETED
-
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)
NCT02526979 ·Status: COMPLETED ·Phase: PHASE1
-
Risk Factors for Treatment Failure in Women With Detrusor Overactivity Receiving Combined Pharmacotherapy
NCT07337252 ·Status: COMPLETED
-
A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug
NCT01565707 ·Status: COMPLETED ·Phase: PHASE3
-
Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children
NCT02327936 ·Status: COMPLETED ·Phase: PHASE3
-
Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)
NCT06465576 ·Status: RECRUITING ·Phase: PHASE4
-
A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)
NCT01099345 ·Status: TERMINATED